NovaBay Pharmaceuticals Determines Unsolicited Offer From Refresh Acquisitions BidCo For An Affiliate Of Refresh To Acquire The Avenova Brand Is A Superior Proposal To Asset Purchase Agreement With PRN Physician Recommended Nutriceuticals,; Under Refresh Offer, Co. Would Receive Purchase Price Of Up To $11.5M, Subject To A Downside Net Working Capital Adjustment
Portfolio Pulse from Benzinga Newsdesk
NovaBay Pharmaceuticals has received an unsolicited offer from Refresh Acquisitions BidCo to acquire the Avenova brand, which is considered superior to a previous agreement with PRN Physician Recommended Nutriceuticals. The offer includes a purchase price of up to $11.5 million, subject to adjustments.
October 29, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NovaBay Pharmaceuticals has received a superior acquisition offer for its Avenova brand from Refresh Acquisitions BidCo, valued at up to $11.5 million, surpassing a previous agreement with PRN.
The unsolicited offer from Refresh Acquisitions BidCo is considered superior to the existing agreement with PRN, indicating a potential positive impact on NovaBay's financials and stock price. The offer's value of up to $11.5 million suggests a favorable outcome for NovaBay.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100